Yuan Q - Search Results

1

Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).

Peng Z, Wang J, Yuan Q, Xiao X, Xu H, Xie Y, Wang W, Huang L, Zhong Y, Ao X, Zhang L, Zhao M, Tao L, Zhou Q; C-STRIDE study group. Peng Z, et al. Among authors: yuan q. BMC Nephrol. 2017 Oct 13;18(1):311. doi: 10.1186/s12882-017-0725-0. BMC Nephrol. 2017. PMID: 29029600 Free PMC article.

2

Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-1beta release.

Tang Y, Li B, Wang N, Xie Y, Wang L, Yuan Q, Zhang F, Qin J, Peng Z, Ning W, Wang L, Hu G, Li J, Tao L. Tang Y, et al. Among authors: yuan q. Int Immunopharmacol. 2010 May;10(5):580-3. doi: 10.1016/j.intimp.2010.02.005. Epub 2010 Feb 13. Int Immunopharmacol. 2010. PMID: 20159052

3

Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.

Yuan Q, Wang R, Peng Y, Fu X, Wang W, Wang L, Zhang F, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Am J Nephrol. 2011;34(2):181-94. doi: 10.1159/000329080. Epub 2011 Jul 23. Am J Nephrol. 2011. PMID: 21791914

4

Vasoactive intestinal peptide enhances TNF-α-induced IL-6 and IL-8 synthesis in human proximal renal tubular epithelial cells by NF-κB-dependent mechanism.

Huang L, Tang Y, Qin J, Peng Y, Yuan Q, Zhang F, Tao L. Huang L, et al. Among authors: yuan q. Inflammation. 2012 Jun;35(3):1154-60. doi: 10.1007/s10753-011-9423-4. Inflammation. 2012. PMID: 22207455

5

Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells.

Yuan Q, Wang L, Zhang F, Wang R, Fu X, Peng Z, Ning W, Hu G, Wang Z, Tao L. Yuan Q, et al. Pharmazie. 2011 Dec;66(12):961-7. Pharmazie. 2011. PMID: 22312703

6

Fluorofenidone attenuates inflammation by inhibiting the NF-кB pathway.

Huang L, Zhang F, Tang Y, Qin J, Peng Y, Wu L, Wang F, Yuan Q, Peng Z, Liu J, Meng J, Tao L. Huang L, et al. Among authors: yuan q. Am J Med Sci. 2014 Jul;348(1):75-80. doi: 10.1097/MAJ.0000000000000187. Am J Med Sci. 2014. PMID: 24534785

7

Expression of Niban in renal interstitial fibrosis.

Liu J, Qin J, Mei W, Zhang H, Yuan Q, Peng Z, Luo R, Yuan X, Huang L, Tao L. Liu J, et al. Among authors: yuan q, yuan x. Nephrology (Carlton). 2014 Aug;19(8):479-89. doi: 10.1111/nep.12266. Nephrology (Carlton). 2014. PMID: 24750539

8

Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis.

Mei W, Peng Z, Lu M, Liu C, Deng Z, Xiao Y, Liu J, He Y, Yuan Q, Yuan X, Tang D, Yang H, Tao L. Mei W, et al. Among authors: yuan q, yuan x. Nephrology (Carlton). 2015 Nov;20(11):832-42. doi: 10.1111/nep.12515. Nephrology (Carlton). 2015. PMID: 25989822

9

The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis.

Tang Y, Zhang F, Huang L, Yuan Q, Qin J, Li B, Wang N, Xie Y, Wang L, Wang W, Kwan K, Peng Z, Hu G, Li J, Tao L. Tang Y, et al. Among authors: yuan q. Am J Med Sci. 2015 Sep;350(3):195-203. doi: 10.1097/MAJ.0000000000000501. Am J Med Sci. 2015. PMID: 26035627

10

Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction.

Liu C, Mei W, Tang J, Yuan Q, Huang L, Lu M, Wu L, Peng Z, Meng J, Yang H, Shen H, Lv B, Hu G, Tao L. Liu C, et al. Among authors: yuan q. PLoS One. 2015 Jun 4;10(6):e0129283. doi: 10.1371/journal.pone.0129283. eCollection 2015. PLoS One. 2015. PMID: 26042668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,664 results

Search Page

Filters